Random-Forest-Algorithm-Based Applications of the Basic Characteristics and Serum and Imaging Biomarkers to Diagnose Mild Cognitive Impairment
- PMID: 35088670
- PMCID: PMC9189735
- DOI: 10.2174/1567205019666220128120927
Random-Forest-Algorithm-Based Applications of the Basic Characteristics and Serum and Imaging Biomarkers to Diagnose Mild Cognitive Impairment
Abstract
Background: Mild cognitive impairment (MCI) is considered the early stage of Alzheimer's Disease (AD). The purpose of our study was to analyze the basic characteristics and serum and imaging biomarkers for the diagnosis of MCI patients as a more objective and accurate approach.
Methods: The Montreal Cognitive Test was used to test 119 patients aged ≥65. Such serum biomarkers were detected as preprandial blood glucose, triglyceride, total cholesterol, Aβ1-40, Aβ1-42, and P-tau. All the subjects were scanned with 1.5T MRI (GE Healthcare, WI, USA) to obtain DWI, DTI, and ASL images. DTI was used to calculate the anisotropy fraction (FA), DWI was used to calculate the apparent diffusion coefficient (ADC), and ASL was used to calculate the cerebral blood flow (CBF). All the images were then registered to the SPACE of the Montreal Neurological Institute (MNI). In 116 brain regions, the medians of FA, ADC, and CBF were extracted by automatic anatomical labeling. The basic characteristics included gender, education level, and previous disease history of hypertension, diabetes, and coronary heart disease. The data were randomly divided into training sets and test ones. The recursive random forest algorithm was applied to the diagnosis of MCI patients, and the recursive feature elimination (RFE) method was used to screen the significant basic features and serum and imaging biomarkers. The overall accuracy, sensitivity, and specificity were calculated, respectively, and so were the ROC curve and the area under the curve (AUC) of the test set.
Results: When the variable of the MCI diagnostic model was an imaging biomarker, the training accuracy of the random forest was 100%, the correct rate of the test was 86.23%, the sensitivity was 78.26%, and the specificity was 100%. When combining the basic characteristics, the serum and imaging biomarkers as variables of the MCI diagnostic model, the training accuracy of the random forest was found to be 100%; the test accuracy was 97.23%, the sensitivity was 94.44%, and the specificity was 100%. RFE analysis showed that age, Aβ1-40, and cerebellum_4_6 were the most important basic feature, serum biomarker, imaging biomarker, respectively.
Conclusion: Imaging biomarkers can effectively diagnose MCI. The diagnostic capacity of the basic trait biomarkers or serum biomarkers for MCI is limited, but their combination with imaging biomarkers can improve the diagnostic capacity, as indicated by the sensitivity of 94.44% and the specificity of 100% in our model. As a machine learning method, a random forest can help diagnose MCI effectively while screening important influencing factors.
Keywords: Machine learning; algorithms; cognitive dysfunction; diagnostic tool; mild cognitive impairment; screening.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Figures
Similar articles
-
Machine-Based Learning Shifting to Prediction Model of Deteriorative MCI Due to Alzheimer's Disease - A Two-Year Follow-Up Investigation.Curr Alzheimer Res. 2022;19(10):708-715. doi: 10.2174/1567205020666221019122049. Curr Alzheimer Res. 2022. PMID: 36278469 Clinical Trial.
-
A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.Neuroimage. 2019 Apr 1;189:276-287. doi: 10.1016/j.neuroimage.2019.01.031. Epub 2019 Jan 14. Neuroimage. 2019. PMID: 30654174
-
Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.J Neurosci Methods. 2018 May 15;302:14-23. doi: 10.1016/j.jneumeth.2017.12.010. Epub 2017 Dec 18. J Neurosci Methods. 2018. PMID: 29269320
-
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. PMID: 24354019 Free Books & Documents. Review.
-
How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database.Neural Regen Res. 2018 Jun;13(6):962-970. doi: 10.4103/1673-5374.233433. Neural Regen Res. 2018. PMID: 29926817 Free PMC article. Review.
Cited by
-
Combining ADC values in DWI with rCBF values in arterial spin labeling (ASL) for the diagnosis of mild cognitive impairment (MCI).Medicine (Baltimore). 2023 Sep 15;102(37):e34979. doi: 10.1097/MD.0000000000034979. Medicine (Baltimore). 2023. PMID: 37713879 Free PMC article.
-
Toward diffusion tensor imaging as a biomarker in neurodegenerative diseases: technical considerations to optimize recordings and data processing.Front Hum Neurosci. 2024 Apr 2;18:1378896. doi: 10.3389/fnhum.2024.1378896. eCollection 2024. Front Hum Neurosci. 2024. PMID: 38628970 Free PMC article. Review.
-
Prediction of patient admission and readmission in adults from a Colombian cohort with bipolar disorder using artificial intelligence.Front Psychiatry. 2023 Dec 21;14:1266548. doi: 10.3389/fpsyt.2023.1266548. eCollection 2023. Front Psychiatry. 2023. PMID: 38179255 Free PMC article.
-
Study protocol for a prediction model for mild cognitive impairment in older adults with diabetes mellitus and construction of a nurse-led screening system: a prospective observational study.BMJ Open. 2024 Feb 7;14(2):e075466. doi: 10.1136/bmjopen-2023-075466. BMJ Open. 2024. PMID: 38326248 Free PMC article.
-
Identification of key immune-related genes and potential therapeutic drugs in diabetic nephropathy based on machine learning algorithms.BMC Med Genomics. 2024 Aug 26;17(1):220. doi: 10.1186/s12920-024-01995-4. BMC Med Genomics. 2024. PMID: 39187837 Free PMC article.
References
-
- Galasko D., Xiao M., Xu D., Smirnov D., Salmon D.P., Dewit N., Vanbrabant J., Jacobs D., Vanderstichele H., Vanmechelen E., Worley P., Alzheimer’s Disease Neuroimaging Initiative (ADNI) Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer’s disease. Alzheimers Dement. (N. Y.) 2019;5(1):871–882. doi: 10.1016/j.trci.2019.11.002. - DOI - PMC - PubMed
-
- Hao X., Bao Y., Guo Y., Yu M., Zhang D., Risacher S.L., Saykin A.J., Yao X., Shen L., Alzheimer’s Disease Neuroimaging Initiative Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer’s disease. Med. Image Anal. 2020;60:101625. doi: 10.1016/j.media.2019.101625. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials